PL3251661T3 - Kompozycja raloksyfenu do posypywania - Google Patents
Kompozycja raloksyfenu do posypywaniaInfo
- Publication number
- PL3251661T3 PL3251661T3 PL17173535T PL17173535T PL3251661T3 PL 3251661 T3 PL3251661 T3 PL 3251661T3 PL 17173535 T PL17173535 T PL 17173535T PL 17173535 T PL17173535 T PL 17173535T PL 3251661 T3 PL3251661 T3 PL 3251661T3
- Authority
- PL
- Poland
- Prior art keywords
- raloxifene
- sprinkle composition
- sprinkle
- composition
- raloxifene sprinkle
- Prior art date
Links
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 title 1
- 229960004622 raloxifene Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201611018447 | 2016-05-30 | ||
| EP17173535.0A EP3251661B1 (en) | 2016-05-30 | 2017-05-30 | Raloxifene sprinkle composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3251661T3 true PL3251661T3 (pl) | 2021-06-14 |
Family
ID=58873696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17173535T PL3251661T3 (pl) | 2016-05-30 | 2017-05-30 | Kompozycja raloksyfenu do posypywania |
Country Status (3)
| Country | Link |
|---|---|
| US (3) | US9872838B2 (pl) |
| EP (1) | EP3251661B1 (pl) |
| PL (1) | PL3251661T3 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3251661T3 (pl) * | 2016-05-30 | 2021-06-14 | Sun Pharmaceutical Industries Limited | Kompozycja raloksyfenu do posypywania |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA57596C2 (uk) | 1996-03-26 | 2003-06-16 | Елі Ліллі Енд Компані | Похідне бензотіофену, фармацевтична лікарська форма, фармацевтична композиція, спосіб лікування остеопорозу та спосіб зниження рівнів ліпідів |
| US6458811B1 (en) | 1996-03-26 | 2002-10-01 | Eli Lilly And Company | Benzothiophenes formulations containing same and methods |
| JP3905990B2 (ja) | 1998-12-25 | 2007-04-18 | 株式会社東芝 | 記憶装置とその記憶方法 |
| AU2003302881A1 (en) * | 2002-12-11 | 2004-06-30 | Ranbaxy Laboratories Limited | Coating composition for taste masking coating and methods for their application and use |
| US20040185170A1 (en) * | 2003-03-21 | 2004-09-23 | Shubha Chungi | Method for coating drug-containing particles and formulations and dosage units formed therefrom |
| US20070092553A1 (en) * | 2005-10-21 | 2007-04-26 | Pfab Lp | Compositions and methods of making rapidly dissolving lonically masked formulations |
| WO2008079963A2 (en) * | 2006-12-22 | 2008-07-03 | Cambrex Charles City, Inc. | Pharmaceutical compositions comprising ionic complexes of active pharmaceutical ingredients |
| CN101631768A (zh) | 2007-03-15 | 2010-01-20 | 太阳医药高级研究有限公司 | 新型前药 |
| WO2008157228A1 (en) * | 2007-06-13 | 2008-12-24 | Cambrex Charles City, Inc. | New methods for taste-masking |
| EP2338480A1 (en) * | 2009-12-22 | 2011-06-29 | LEK Pharmaceuticals d.d. | Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt |
| EP2709593A4 (en) | 2011-05-16 | 2014-10-29 | Sun Pharma Advanced Res Co Ltd | PHARMACEUTICAL COMPOSITION OF MULTIPLE PARTICLES |
| PL3251661T3 (pl) * | 2016-05-30 | 2021-06-14 | Sun Pharmaceutical Industries Limited | Kompozycja raloksyfenu do posypywania |
-
2017
- 2017-05-30 PL PL17173535T patent/PL3251661T3/pl unknown
- 2017-05-30 US US15/608,387 patent/US9872838B2/en active Active
- 2017-05-30 EP EP17173535.0A patent/EP3251661B1/en active Active
- 2017-12-12 US US15/839,221 patent/US10092522B2/en active Active
-
2018
- 2018-07-31 US US16/050,199 patent/US10335376B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US9872838B2 (en) | 2018-01-23 |
| US10092522B2 (en) | 2018-10-09 |
| US10335376B2 (en) | 2019-07-02 |
| US20180098943A1 (en) | 2018-04-12 |
| EP3251661A1 (en) | 2017-12-06 |
| US20180333364A1 (en) | 2018-11-22 |
| EP3251661B1 (en) | 2020-12-23 |
| US20170340573A1 (en) | 2017-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201600075D0 (en) | Immunogenci composition | |
| GB201700504D0 (en) | Composition | |
| PL3443034T3 (pl) | Kompozycja | |
| GB201612658D0 (en) | Composition | |
| GB201617908D0 (en) | Composition | |
| GB201610628D0 (en) | New compositions | |
| GB201611782D0 (en) | Composition | |
| ZA201901222B (en) | Composition comprising duddingtonia flagrans | |
| GB2573378B (en) | Composition | |
| GB201612359D0 (en) | Composition | |
| GB201602579D0 (en) | New compositions | |
| PL3251661T3 (pl) | Kompozycja raloksyfenu do posypywania | |
| GB201700095D0 (en) | Composition | |
| GB201620846D0 (en) | Composition | |
| GB201615908D0 (en) | Pharmaceautical composition | |
| GB201607924D0 (en) | Composition | |
| GB201720891D0 (en) | New composition | |
| GB201700618D0 (en) | Composition | |
| GB201620914D0 (en) | Composition | |
| GB201620792D0 (en) | Composition | |
| GB201619630D0 (en) | Composition | |
| GB201618062D0 (en) | Composition | |
| GB201616772D0 (en) | Composition | |
| GB201616785D0 (en) | Composition | |
| GB201615461D0 (en) | Composition |